KHN Morning Briefing

Summaries of health policy coverage from major news organizations.

Study Suggests 2004 Lawsuit Fueled Big Spending On Epilepsy Drugs

Reuters: Did the Neurontin Lawsuit Fuel Health Spending?
In 2004, Pfizer, the world's largest drug company, agreed to plead guilty and pay more than $430 million to settle charges it had illegally marketed the epilepsy drug Neurontin for unapproved uses. Now, a study in the Journal of Clinical Psychiatry questions whether the lawsuit ended up fueling spending on other epilepsy drugs instead of curbing so-called off-label prescribing (Joelving, 10/26).

This is part of the KHN Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.